Altimmune (ALT) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Altimmune (ALT) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
18.06% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-303.06% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
67.94% |
| 10 |
Altimmune |
336.67 Mn |
336.67 Mn |
- |
99.90% |
| Date | Value |
|---|
| Mar 31, 2026 |
99.90% |
| Dec 31, 2025 |
99.87% |
| Sep 30, 2025 |
98.98% |
| Jun 30, 2025 |
99.68% |
| Mar 31, 2025 |
18.58% |
| Dec 31, 2024 |
-47.91% |
| Sep 30, 2024 |
-431.09% |
| Jun 30, 2024 |
-197.05% |
| Mar 31, 2024 |
-146.28% |
| Dec 31, 2023 |
-13,421.66% |
| Sep 30, 2023 |
-100.97% |
| Jun 30, 2023 |
-2,769.47% |
| Mar 31, 2023 |
-3,359.30% |
| Dec 31, 2022 |
-67.38% |
| Sep 30, 2022 |
61.56% |
| Jun 30, 2022 |
72.24% |
| Mar 31, 2022 |
74.60% |
| Dec 31, 2021 |
107.03% |
| Sep 30, 2021 |
87.51% |
| Jun 30, 2021 |
79.70% |
